MedPath

SE OF OXYTOCIN DURING EMERGENCY CESAREAN SECTION: A STUDY COMPARING OXYTOCIN INFUSION WITH & WITHOUT OXYTOCIN BOLUS

Not Applicable
Conditions
Health Condition 1: null- women for emergency cesarean section
Registration Number
CTRI/2013/12/004193
Lead Sponsor
Dr RPGMC Kangra at Tanda HP
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

•Singleton pregnancy/Woman for emergency caesarean section as per obstetrical indication/Period of gestation between 36 to 41 weeks

Exclusion Criteria

•Twin pregnancy /severe pre-eclampsia/ HELLP syndrome/Co-agulopathy/Abruptio placentae/Intra-uterine fetal death/Malformed fetus/Uncontrolled diabetes mellitus/Chorio-amniotis/Known case of thrombophilia/ Known case of chronic Renal or liver disease /previous classical caesarean section/ hysterotomy/previous uterine surgery (caesarean section, myomectomy, hysterotomy, polypectomy, lysis of uterine synechia, or hysteroscopic metroplasty)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PRIMARY OUTCOME <br/ ><br>The primary outcome is major obstetrical hemorrhage following caesarean section. (defined as blood loss 1000ml ). <br/ ><br>Timepoint: 24 hours after LSCS
Secondary Outcome Measures
NameTimeMethod
â?¢Hemodynamic profile ( BP, mean arterial pressure, pulse rate) <br/ ><br>â?¢Severe anemia ( 20% fall in Hb post operative) <br/ ><br>â?¢Need of blood transfusion <br/ ><br>â?¢Side effect profile <br/ ><br>â?¢Duration of surgery <br/ ><br>â?¢Need for manual removal of placenta <br/ ><br>Timepoint: 24 hours after LSCS
© Copyright 2025. All Rights Reserved by MedPath